MTOR and Angelman syndrome: We recently reported that LAMTOR1 is a target of the UBE3A ubiquitin ligase, which is downregulated in Angelman syndrome (AS), thereby implicating changes in lysosomal distribution, function and mTOR signaling in the etiology of AS (Sun et al., 2018).